CLINICAL_TRIALS
research
· 2025-06-03
Clinical Trial Update: Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression [Phase 4]
Summary
A Phase 4 comparative effectiveness study examining two forms of ketamine for treatment-resistant depression is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The George Institute | Conditions: Treatment Resistant Depression | Phase 4 | Status: RECRUITING